Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.

Article 

Google Scholar 

Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, et al. Observational Cohorts in Japan (EPOCH-JAPAN) research group. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res. 2012;35:947–53.

Article 
PubMed 

Google Scholar 

Lawes CM, Vander Hoorn S, Rodgers A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.

Article 
PubMed 

Google Scholar 

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

Article 
PubMed 

Google Scholar 

Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, et al. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022. J Atheroscler Thromb. 2024;31:641–853.

Article 
CAS 
PubMed 

Google Scholar 

Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11:165–223.

Article 
PubMed 
PubMed Central 

Google Scholar 

Lusk SL, Raymond DM 3rd. Impacting health through the worksite. Nurs Clin North Am. 2002;37:247–56.

Article 
PubMed 

Google Scholar 

Okamura T, Sugiyama D, Tanaka T, Dohi S. Worksite wellness for the primary and secondary prevention of cardiovascular disease in Japan: the current delivery system and future directions. Prog Cardiovasc Dis. 2014;56:515–21.

Article 
PubMed 

Google Scholar 

Satoh A, Arima H, Ohkubo T, Nishi N, Okuda N, Ae R, et al. NIPPON DATA2010 Research Group. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens. 2017;35:401–8.

Article 
CAS 
PubMed 

Google Scholar 

Hashiguchi K, Nagata T, Mori K, Nagata M, Fujino Y, Ito M. Occupational health services improve effective coverage for hypertension and diabetes mellitus at Japanese companies. J UOEH. 2019;41:271–82.

Article 
PubMed 

Google Scholar 

Nagata M, Nagata T, Takahashi H, Mori K. Association of organizational factors with the proportion of healthy behaviours and control of blood pressure at a company level. J Occup Environ Med. 2022;64:34–8.

Article 
PubMed 

Google Scholar 

Aono Y, Aisaka A, Gohno M, Hida T, Shimizu T. Visiting a doctor by individuals who need medical diagnosis after screening and kinds of screening. Occup Health J. 2000;23:43–9. (in Japanese)

Google Scholar 

The Small and Medium Enterprise Agency. 2023 White Paper on Small and Medium Enterprises in Japan. https://www.meti.go.jp/english/press/2023/pdf/0428_005a.pdf (in Japanese) (Accessed September 9, 2024).

Ministry of Health, Labour and Welfare of Japan. An Outline of the Japanese Medical System. https://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/01_eng.pdf (Accessed September 9, 2024).

Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, et al. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J. 2008;49:193–203.

Article 
PubMed 

Google Scholar 

Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011;18:629–39.

Article 
CAS 
PubMed 

Google Scholar 

Ministry of Health, Labour and Welfare of Japan. The Standard Classification of Business Category for Employees’ Health Insurance and Employees’ Pension Insurance. https://www.mhlw.go.jp/web/t_doc?dataId=00tc6845&dataType=1&pageNo=1 (in Japanese) (Accessed September 9, 2024).

Ministry of Health, Labour and Welfare of Japan. The Basic Guideline for Health Checkups and Healthcare Advice with a Particular Focus on the Metabolic Syndrome (edition of year 2018). https://www.mhlw.go.jp/content/10900000/000496784.pdf (in Japanese) (Accessed September 9, 2024).

Tanno K, Okamura T, Ohsawa M, Onoda T, Itai K, Sakata K, et al. Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population. Clin Chim Acta. 2010;411:1774–80.

Article 
CAS 
PubMed 

Google Scholar 

World Health Organization. International Classification of Disease, Tenth Revision (ICD-10). https://icd.who.int/browse10/2019/en (Accessed September 9, 2024).

Kuriyama A, Takahashi Y, Tsujimura Y, Miyazaki K, Satoh T, Ikeda S, et al. Predicting failure to follow-up screened high blood pressure in Japan: a cohort study. J Public Health (Oxf). 2015;37:498–505.

Article 
PubMed 

Google Scholar 

Fukuma S, Ikenoue T, Saito Y, Yamada Y, Saigusa Y, Misumi T, et al. Lack of a bridge between screening and medical management for hypertension: health screening cohort in Japan. BMC Public Health. 2020;20:1419.

Article 
PubMed 
PubMed Central 

Google Scholar 

Yamaguchi N, Ohkubo T, Funatani F, Yamamura J, Takahashi K, Nakamura R. A prospective study of access to medical services following a community- based screening program. Jpn J Public Health. 1990;37:281–7. (in Japanese)

CAS 

Google Scholar 

Goto E, Ishikawa H, Okuhara T, Okada H, Tsunezumi A, Kagawa Y, et al. Factors associated with adherence to recommendations for medical visits following annual health checkups among Japanese employees: a prospective cohort study. Prev Med Rep. 2023;37:102565.

Article 
PubMed 
PubMed Central 

Google Scholar 

Shima A, Arima H, Miura K, Tatsumi Y, Ohkubo T, Kawatsu Y, et al. Cluster-randomized controlled trial for the early promotion of clinic visits for untreated hypertension. Hypertens Res. 2021;44:355–62.

Article 
PubMed 

Google Scholar 

Kadota A, Okuda N, Ohkubo T, Okamura T, Nishi N, Ueshima H, et al. The national integrated project for prospective observation of non-communicable disease and its trends in the aged 2010 (NIPPON DATA2010): objectives, design, and population characteristics. J Epidemiol. 2018;28:S2–S9.

Article 
PubMed 
PubMed Central 

Google Scholar 

Tsuji M, Arima H, Ohkubo T, Nakamura K, Takezaki T, Sakata K, et al. Socioeconomic status and knowledge of cardiovascular risk factors: NIPPON DATA2010. J Epidemiol. 2018;28:S46–S52.

Article 
PubMed 
PubMed Central 

Google Scholar 

Tanaka T, Okamura T, Yamagata Z, Takebayashi T, Tamura U, Kusaka Y, et al. HIPOP-OHP Research Group. Awareness and treatment of hypertension and hypercholesterolemia in Japanese workers: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res. 2007;30:921–8.

Article 
PubMed 

Google Scholar 

Fukumine Y, Nakamura K. Obesity and hypertension from a public health perspective in a small remote island of Okinawa, Japan. Hypertens Res. 2023;46:1850–9.

Article 
PubMed 

Google Scholar 

Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto S, et al. Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring). 2010;18:153–60.

Article 
CAS 
PubMed 

Google Scholar 

Japan Organization of Occupational Health and Safety. Occupational Health Centers. https://www.johas.go.jp/shisetsu/tabid/578/Default.aspx (in Japanese) (Accessed September 9, 2024).

Takeuchi M, Kikuchi A, Ishibiki T, Mitsuhata K, Hiranuma Y, Ono Y, et al. Efforts to encourage health check-up examinees to undergo further examinations and their results. Ningen Dock. 2014;29:471–6. (in Japanese)

Google Scholar 

Kuzuya Y, Akagawa C, Akatsuka N, Furuta H, Ogawa K, Seya A, et al. Investigation of methods for recommending detailed medical examination that lead to consultation behavior: questionnaire survey focusing on the timing of undergoing detailed examination and factors that promote consultation behavior. Ningen Dock. 2022;37:664–74. (in Japanese)

Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80. (Errata: Lancet 2022;399:520)

Article 

Google Scholar 

AloJapan.com